4-109743474-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000204.5(CFI):​c.1430-879A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 152,110 control chromosomes in the GnomAD database, including 52,372 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.81 ( 52372 hom., cov: 31)

Consequence

CFI
NM_000204.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.841

Publications

10 publications found
Variant links:
Genes affected
CFI (HGNC:5394): (complement factor I) This gene encodes a serine proteinase that is essential for regulating the complement cascade. The encoded preproprotein is cleaved to produce both heavy and light chains, which are linked by disulfide bonds to form a heterodimeric glycoprotein. This heterodimer can cleave and inactivate the complement components C4b and C3b, and it prevents the assembly of the C3 and C5 convertase enzymes. Defects in this gene cause complement factor I deficiency, an autosomal recessive disease associated with a susceptibility to pyogenic infections. Mutations in this gene have been associated with a predisposition to atypical hemolytic uremic syndrome, a disease characterized by acute renal failure, microangiopathic hemolytic anemia and thrombocytopenia. Primary glomerulonephritis with immune deposits and age-related macular degeneration are other conditions associated with mutations of this gene. [provided by RefSeq, Dec 2015]
CFI Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • atypical hemolytic-uremic syndrome with I factor anomaly
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complement factor I deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • Doyne honeycomb retinal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • age related macular degeneration 13
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.928 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFINM_000204.5 linkc.1430-879A>G intron_variant Intron 11 of 12 ENST00000394634.7 NP_000195.3 P05156A8K3L0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFIENST00000394634.7 linkc.1430-879A>G intron_variant Intron 11 of 12 1 NM_000204.5 ENSP00000378130.2 P05156
ENSG00000285330ENST00000645635.1 linkc.1430-879A>G intron_variant Intron 11 of 14 ENSP00000493607.1 A0A2R8Y3M9

Frequencies

GnomAD3 genomes
AF:
0.807
AC:
122661
AN:
151992
Hom.:
52358
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.498
Gnomad AMI
AF:
0.977
Gnomad AMR
AF:
0.911
Gnomad ASJ
AF:
0.923
Gnomad EAS
AF:
0.850
Gnomad SAS
AF:
0.845
Gnomad FIN
AF:
0.942
Gnomad MID
AF:
0.889
Gnomad NFE
AF:
0.934
Gnomad OTH
AF:
0.851
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.807
AC:
122709
AN:
152110
Hom.:
52372
Cov.:
31
AF XY:
0.810
AC XY:
60193
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.497
AC:
20611
AN:
41436
American (AMR)
AF:
0.912
AC:
13942
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.923
AC:
3202
AN:
3470
East Asian (EAS)
AF:
0.850
AC:
4385
AN:
5156
South Asian (SAS)
AF:
0.846
AC:
4079
AN:
4824
European-Finnish (FIN)
AF:
0.942
AC:
9981
AN:
10594
Middle Eastern (MID)
AF:
0.898
AC:
264
AN:
294
European-Non Finnish (NFE)
AF:
0.934
AC:
63563
AN:
68022
Other (OTH)
AF:
0.849
AC:
1791
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
932
1865
2797
3730
4662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
854
1708
2562
3416
4270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.906
Hom.:
132297
Bravo
AF:
0.792
Asia WGS
AF:
0.801
AC:
2784
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.54
DANN
Benign
0.59
PhyloP100
-0.84
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11726949; hg19: chr4-110664630; API